<13 Weeks’ Gestation
Pregnancy Termination1
800 ?g sublingual administration every 3 hours
or vaginal administration / buccal every 3-12 hours (2–3 doses)
Missed Abortion2
800 ?g vaginal administration every 3 hours (x2)
or 600 ?g sublingual administration every 3 hours (x2)
Incomplete Abortion2,3,4
600 ?g oral administration (x1)
or 400 ?g sublingual administration (x1)
or 400-800 ?g vaginal administration (x1)
Cervical Preparation for Surgical Abortion
400 ?g sublingual administration 1 hour before procedure
or vaginal administration 3 hours before procedure
13–26 Weeks’ Gestation
Pregnancy Termination1,5,6
13–24 weeks: 400 ?g vaginal / sublingual / buccal administration every 3 hours
25–26 weeks: 200 ?g vaginal / sublingual / buccal administration every 4 hours
Foetal Death1,5,6
200 ?g vaginal / sublingual / buccal administration every 4–6 hours
Inevitable Abortion2,3,5,6,7
200 ?g vaginal / sublingual / buccal administration every 6 hours
Cervical Preparation for Surgical Abortion
13–19 weeks: 400 ?g vaginal administration 3-4 hours before procedure
>19 weeks: needs to be combined with other modalities
>26 Weeks’ Gestation8
Pregnancy Termination1,5,9
27–28 weeks: 200 ?g vaginal / sublingual / buccal administration every 4 hours
>28 weeks: 100 ?g vaginal / sublingual / buccal administration every 6 hours
Foetal Death2,9
27–28 weeks: 100 ?g vaginal / sublingual / buccal administration every 4 hours
>28 weeks: 25 ?g vaginal administration every 6 hours
or 25 ?g oral administration every 2 hours
Induction of Labour2,9
25 ?g vaginal administration every 6 hours
or 25 ?g oral administration every 2 hours
Postpartum Use
Postpartum Haemorrhage (PPH) Prophylaxis2,10
600 ?g oral administration (x1)
or PPH Secondary Prevention11 (approx. ≥350ml blood loss)
800 ?g sublingual administration (x1)
PPH Treatment2,10
800 ?g sublingual administration (x1)
1 If mifepristone is available (preferable), follow the regimen prescribed for mifepristone + misoprostol
2 Included in the WHO Model List of Essential Medicines
3 For incomplete/inevitable abortion women should be treated based on their uterine size rather than last menstrual period (LMP) dating
4 Leave to take effect over 1–2 weeks unless excessive bleeding or infection
5 An additional dose can be offered if the placenta has not been expelled 30 minutes after foetal expulsion
6 Several studies limited dosing to 5 times; most women have complete expulsion before use of 5 doses, but other studies continued beyond 5 and achieved a higher total success rate with no safety issues
7 Including ruptured membranes where delivery indicated
8 Follow local protocol if previous caesarean or transmural uterine scar
9 If only 200 ?g tablets are available, smaller doses can be made by dissolving in water
10 Where oxytocin is not available or storage conditions are inadequate
11 Option for community based programs
Int J Gynaecol Obstet. 2017;138(3):363-366.